Pfizer Inc.’s maternal vaccine to protect newborns against the sometimes fatal RSV virus can be administered across the US ...

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns WASHINGTON -- U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their ...

FRIDAY, Sept. 22, 2023 (HealthDay News) -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV). Following approval one ...

The Food and Drug Administration approved Abrysvo, Pfizer’s respiratory syncytial virus (RSV) vaccine, for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD ...

The FDA approved the first vaccine for pregnant women to prevent RSV in infants. The vaccine would allow babies to be born ...

NEW YORK (AP) — U.S. health officials on Friday recommended RSV vaccinations for moms-to-be, a second new option to protect ...

The new shots are similar to previously approved formulas but were updated to target strains of the virus descended from ...

The federal Food and Drug Administration approved the Pfizer Covid-19 vaccine for emergency use in children ages 5 to 11 this morning, opening the door for vaccinations to begin. Before that can ...

The Food and Drug Administration authorized the emergency use of its Pfizer-BioNTech vaccine for adolescents age 12 to 15 today, according to the New York Times. Authorization is given for the ...

The US Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their ...

The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...